Title : Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells.

Pub. Date : 2020 Dec

PMID : 32653978

1 Functional Relationships(s)
Compound Name
Protein Name
1 Here, we studied the effect of Stattic (STAT3 inhibitor) loaded in nanostructured lipid carriers (NLCs) on enhancing the efficacy, cytotoxicity, and induction of apoptosis of doxorubicin in B16F10 mouse melanoma cancer cell. stattic signal transducer and activator of transcription 3 Mus musculus